Language

News topic

Product ARIPIPRAZOLE

Current shortage notices for the product family ARIPIPRAZOLE, structured by product, country and reporting period.

7 notices

← All shortages

What the ARIPIPRAZOLE notices indicate for the supply chain

The 7 consolidated notices from Belgium, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 28 (28 x 1) UD

Active ingredient: Aripiprazole

View notice details →
Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 98

Active ingredient: Aripiprazole

View notice details →
Belgium

Aripiprazole Mylan Pharma 10 mg tabl. 98

Active ingredient: Aripiprazole

View notice details →
Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 28 (28 x 1) UD

Active ingredient: Aripiprazole

View notice details →
Belgium

Aripiprazole Mylan Pharma 15 mg tabl. 98

Active ingredient: Aripiprazole

View notice details →